Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges

Tekijä Birkeland, A.C., Owen, J.H., Prince, M.E.
Julkaisussa J Dent Res (2015)

Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer

Tekijä Tan, Y.S., Sansanaphongpricha, K., Prince, M.E.P., Sun, D., Wolf, G.T., Lei, Y.L.
Julkaisussa J Dent Res (2018)

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

Tekijä Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., Weissman, I. L., Clarke, M. F., Ailles, L. E.
Julkaistu 2007

Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells

Tekijä Subramanian, C., Kovatch, K.J., Sim, M.W., Wang, G., Prince, M.E., Carey, T.E., Davis, R., Blagg, B.S.J., Cohen, M.S.
Julkaisussa Neoplasia (2017)

Rationale for the Advancement of PI3K Pathway Inhibitors for Personalized Chordoma Therapy

Tekijä Michmerhuizen, N.L., Owen, J.H., Heft Neal, M.E., Mann, J.E., Leonard, E., Wang, J., Zhai, J., Jiang, H., McHugh, J.B., Brenner, J.C., Prince, M.E.P.
Julkaisussa J Neurooncol (2020)

Evaluation of CD44 variants expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance

Tekijä Athanassiou-Papaefthymiou, M., Shkeir, O., Kim, D., Divi, V., Matossian, M., Owen, J. H., Czerwinski, M. J., Papagerakis, P., McHugh, J., Bradford, C. R., Carey, T. E., Wolf, G. T., Prince, M. E., Papagerakis, S.
Julkaisussa Int J Immunopathol Pharmacol (2014)